Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
International Journal of Molecular Sciences
|
January 10, 2019
Kinetics and Predicted Structure of a Novel Xylose Reductase from <i>Chaetomium thermophilum</i>
Julian Quehenberger, Tom Reichenbach, Niklas Baumann, et al.
Frontiers in Immunology
|
July 22, 2022
Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?
Chilam Chan, Marta Lustig, Niklas Baumann, et al.
Frontiers in Immunology
|
September 30, 2022
Corrigendum: Targeting myeloid checkpoint molecules in combination with antibody therapy: A novel anti-cancer strategy with IgA antibodies?
Chilam Chan, Marta Lustig, Niklas Baumann, et al.
Anesthesia and Analgesia
|
May 6, 2025
Spectral Differences of Anesthetic Agents: Addressing Fundamental Problems With New Methods
Srdjan Z Dragovic, Julian Ostertag, Niklas Baumann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 23, 2023
Bispecific Complement Engagers for Targeted Complement Activation
Dennis V Pedersen, Heidi Gytz, Mikael B L Winkler, et al.
Scientific Reports
|
December 2, 2020
DNA aptamers against bacterial cells can be efficiently selected by a SELEX process using state-of-the art qPCR and ultra-deep sequencing
Claudia Kolm, Isabella Cervenka, Ulrich J Aschl, et al.
Frontiers in Immunology
|
September 2, 2022
Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab
Niklas Baumann, Christian Arndt, Judith Petersen, et al.
Blood Advances
|
September 15, 2021
The selection of variable regions affects effector mechanisms of IgA antibodies against CD20
Mitchell Evers, Thies Rösner, Anna Dünkel, et al.
Cancer Science
|
May 31, 2021
Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions
Niklas Baumann, Thies Rösner, J H Marco Jansen, et al.
Frontiers in Immunology
|
June 22, 2023
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells
Marta Lustig, Chilam Chan, J H Marco Jansen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
International Journal of Molecular Sciences
|
January 10, 2019
Kinetics and Predicted Structure of a Novel Xylose Reductase from <i>Chaetomium thermophilum</i>
Julian Quehenberger, Tom Reichenbach, Niklas Baumann, et al.
Frontiers in Immunology
|
July 22, 2022
Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?
Chilam Chan, Marta Lustig, Niklas Baumann, et al.
Frontiers in Immunology
|
September 30, 2022
Corrigendum: Targeting myeloid checkpoint molecules in combination with antibody therapy: A novel anti-cancer strategy with IgA antibodies?
Chilam Chan, Marta Lustig, Niklas Baumann, et al.
Anesthesia and Analgesia
|
May 6, 2025
Spectral Differences of Anesthetic Agents: Addressing Fundamental Problems With New Methods
Srdjan Z Dragovic, Julian Ostertag, Niklas Baumann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 23, 2023
Bispecific Complement Engagers for Targeted Complement Activation
Dennis V Pedersen, Heidi Gytz, Mikael B L Winkler, et al.
Scientific Reports
|
December 2, 2020
DNA aptamers against bacterial cells can be efficiently selected by a SELEX process using state-of-the art qPCR and ultra-deep sequencing
Claudia Kolm, Isabella Cervenka, Ulrich J Aschl, et al.
Frontiers in Immunology
|
September 2, 2022
Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab
Niklas Baumann, Christian Arndt, Judith Petersen, et al.
Blood Advances
|
September 15, 2021
The selection of variable regions affects effector mechanisms of IgA antibodies against CD20
Mitchell Evers, Thies Rösner, Anna Dünkel, et al.
Cancer Science
|
May 31, 2021
Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions
Niklas Baumann, Thies Rösner, J H Marco Jansen, et al.
Frontiers in Immunology
|
June 22, 2023
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells
Marta Lustig, Chilam Chan, J H Marco Jansen, et al.
Page
of 2